For three decades University College London neurogeneticist John Hardy and like-minded scholars have been so dominant in promoting the theory that amyloid-beta plaques are the root cause of ...

A Nigerian researcher, Isreal Onifade, has identified plant compounds that could help in the treatment of Alzheimer’s disease.

Research supporting the amyloid hypothesis—the idea that Alzheimer's is caused by a buildup of amyloid plaques in the brain—was fraudulent.

But the theory remains controversial: all brains with Alzheimer’s show beta-amyloid plaques, yet not everyone with these plaques experiences cognitive decline.

The amyloid hypothesis holds that sticky plaques and other so-called amyloid-beta proteins build up in the brain and prompt changes that cause Alzheimer’s disease’s cruel decline, gradually ...

Paul Rand: Inside your book, you spend a good amount of time talking about the role that you think that government funding organizations, not-for-profit organizations, pharma companies, and so forth ...

The researchers found that for every one-point increase in the healthy lifestyle score, the lower the amount of beta-amyloid plaques (hallmarks of Alzheimer’s disease) and the higher their score ...

They argue that the finding that showed that removing amyloid-beta slowed the disease progression is a "proof of principal" that the amyloid plaques are what drive it.

Not all of these signs need to be present for a person to be diagnosed with Alzheimer’s disease, although the presence of amyloid-beta plaques and/or tau tangles in the brain are essential ...

After 30 years of intensive research, science is nowhere near a cure for Alzheimer’s disease — an illness that affects more than 55 million people worldwide. Are we doing something wrong?

One of the early signs of Alzheimer's disease is the buildup of fragments of proteins called amyloid beta, which stick together in plaquelike clumps in the brain.